- Home
- BLNK vs XGN Comparison
BLNK vs XGN Comparison
Compare BLNK & XGN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- BLNK
- XGN
- Stock Information
- Founded
- BLNK 2009
- XGN 2002
- Country
- BLNK United States
- XGN United States
- Employees
- BLNK 706
- XGN N/A
- Industry
- BLNK Industrial Specialties
- XGN Medical Specialities
- Sector
- BLNK Consumer Discretionary
- XGN Health Care
- Exchange
- BLNK Nasdaq
- XGN Nasdaq
- Market Cap
- BLNK 103.7M
- XGN 86.6M
- IPO Year
- BLNK N/A
- XGN 2019
- Fundamental
- Price
- BLNK $1.03
- XGN $3.58
- Analyst Decision
- BLNK Buy
- XGN Strong Buy
- Analyst Count
- BLNK 8
- XGN 2
- Target Price
- BLNK $5.24
- XGN $7.50
- AVG Volume (30 Days)
- BLNK 4.1M
- XGN 153.9K
- Earning Date
- BLNK 03-13-2025
- XGN 03-17-2025
- Dividend Yield
- BLNK N/A
- XGN N/A
- EPS Growth
- BLNK N/A
- XGN N/A
- EPS
- BLNK N/A
- XGN N/A
- Revenue
- BLNK $138,728,000.00
- XGN $55,751,000.00
- Revenue This Year
- BLNK N/A
- XGN $7.13
- Revenue Next Year
- BLNK $22.16
- XGN $19.14
- P/E Ratio
- BLNK N/A
- XGN N/A
- Revenue Growth
- BLNK 15.13
- XGN 8.00
- 52 Week Low
- BLNK $0.92
- XGN $1.30
- 52 Week High
- BLNK $3.75
- XGN $6.22
- Technical
- Relative Strength Index (RSI)
- BLNK 29.72
- XGN 38.58
- Support Level
- BLNK $0.92
- XGN $3.63
- Resistance Level
- BLNK $1.19
- XGN $4.55
- Average True Range (ATR)
- BLNK 0.07
- XGN 0.50
- MACD
- BLNK 0.00
- XGN -0.13
- Stochastic Oscillator
- BLNK 36.21
- XGN 2.75
About BLNK Blink Charging Co.
Blink Charging Co is an owner, operator, and provider of electric vehicle (EV) charging services. The company offers both residential and commercial EV charging equipment, enabling EV drivers to easily recharge at various location types. The company's business is the sale and distribution of electric vehicle charging equipment and its associated revenues earned from customers and/or Property Partners who use equipment connected to its network. It earns majority revenue from U.S.A.
About XGN Exagen Inc.
Exagen Inc is a commercial-stage diagnostics company committed to addressing the unmet need for the accurate diagnosis and monitoring of patients affected by autoimmune rheumatic diseases. It currently markets ten testing products under its Avise brand to provide an accurate, timely, and differential diagnosis and to optimize the treatment of ARDs. It markets and sells solutions to community rheumatologists.